Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Inflammation and Regeneration|April 27, 2025
NRP2+ human mesenchymal stem cells have stemness-associated propertiesKotaro Tanaka, Rintaro Yoshikawa, Satoru Miyagi, et al.Japanese Journal of Clinical Oncology|June 15, 2018
Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study)Kenichi Miyamoto, Noriko Fukuhara, Dai Maruyama, et al.Inflammation and Regeneration|March 1, 2022
Generation of a BAC transgenic mouse strain that expresses CreERT and a fluorescent protein under the transcriptional control of the Fzd5 locusSatoru Miyagi, Yuko Kato, Ayako Watanabe, et al.International Archives of Allergy and Immunology|May 11, 2006
Histamine type 1 receptor deficiency reduces airway inflammation in a murine asthma modelKenichi Miyamoto, Michiko Iwase, Miki Nyui, et al.International Journal of Hematology|August 30, 2018
Chronic myeloid leukemia stem cells and molecular target therapies for overcoming resistance and disease persistenceAi Inoue, Chiharu I Kobayashi, Haruka Shinohara, et al.Japanese Journal of Clinical Oncology|November 15, 2017
A Phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III)Kenichi Miyamoto, Akihiro Ito, Masashi Wakabayashi, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2019
[Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration]Toshiki Terao, Junichiro Yuda, Nobuhiko Yamauchi, et al.International Journal of Clinical Oncology|October 28, 2020
Comparison of the International Workshop Criteria and the Response Evaluation Criteria in Solid Tumors for indolent B-cell lymphomaKenichi Miyamoto, Takashi Watanabe, Masashi Wakabayashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
[Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination]Sachio Fushida, Nao Furui, Shinichi Kinami, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 31, 2002
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination]Sachio Fushida, Furui Nao, Shinichi Kinami, et al.Pageof 6